NTLA Intellia Therapeutics Inc

USD 17.84 -0.15 ( -0.83)%
Icon

Intellia Therapeutics Inc (NTLA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 17.84

-0.15 (-0.83)%

USD 1.83B

1.60M

USD 50.15(+181.13%)

USD 59.56 (+233.86%)

Icon

NTLA

Intellia Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 17.84
-0.15 ( -0.83)%

ETFs Holding Intellia Therapeutics Inc (NTLA)

Symbol Name Exchange NTLA's Weight Expense Ratio Price(Change) Market Cap
ARKG:LSE
ARK Genomic Revolution UC.. LSE 4.80 % 0.00 % -0.01 (-0.22%) USD2.96M

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...